SCHEMBL698560

SCHEMBL698560

CC(=Nc1c(C)cccc1Cl)c1cccc(C(C)=Nc2c(C(C)C)cccc2C(C)C)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.36
CTSA P10619 3/20 0.32
GABRA1 P14867 2/20 0.32
GABRG2 P18507 2/20 0.32
GABRB3 P28472 2/20 0.32
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 2/20 0.31
FAAH O00519 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
GABRB1 P18505 1/20 0.31
PTGS1 P23219 1/20 0.31
SLC6A2 P23975 1/20 0.31
HTR2C P28335 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31
HTR2B P41595 1/20 0.31
GABRA2 P47869 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL698559 1.00 LMNA (0.36) LMNACTSAGABRA1GABRG2GABRB3
Hydrochloric Acid SCHEMBL20703669 0.97 LMNA (0.35) LMNACTSAGABRA1GABRG2GABRB3
Hydrochloric Acid SCHEMBL20703671 0.97 LMNA (0.35) LMNACTSAGABRA1GABRG2GABRB3
Hydrochloric Acid SCHEMBL28402656 0.97 LMNA (0.35) LMNACTSAGABRA1GABRG2GABRB3
SCHEMBL25647101 0.97 LMNA (0.36) LMNACTSAGABRA1GABRG2GABRB3
SCHEMBL20703670 0.96 LMNA (0.34) LMNACTSA
SCHEMBL18543889 0.90 GABRA1 (0.36) LMNACTSAGABRA1GABRG2GABRB3
SCHEMBL6906013 0.90 GABRA1 (0.36) LMNACTSAGABRA1GABRG2GABRB3
SCHEMBL1776465 0.89 GABRA1 (0.37) LMNACTSAGABRA1GABRG2GABRB3
SCHEMBL1776466 0.89 GABRA1 (0.37) LMNACTSAGABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1971577-B1 Process for the preparation of unsymmetric bis(imino) compounds BASELL POLYOLEFINE GMBH (DE) 2014-11-26 EP disclosed
US-8252875-B2 Process for the preparation of unsymmetric bis(imino) compounds BASELL POLYOLEFINE GMBH (DE) 2012-08-28 US disclosed
EP-2423193-A1 Process for preparing imino compounds Basell Polyolefine GmbH (DE) 2012-02-29 EP disclosed
US-7795441-B2 Process for preparing imino compounds BASELL POLYOLEFINE GMBH (DE) 2010-09-14 US disclosed
US-20090054609-A1 Process for the Preparation of Unsymmetric Bis(Imino) Compounds BASELL POLYOLEFINE GMBH (DE) 2009-02-26 US disclosed
US-20090005571-A1 Process for Preparing Imino Compounds BASELL POLYOLEFINE GMBH (DE) 2009-01-01 US disclosed
EP-1971577-A2 PROCESS FOR THE PREPARATION OF UNSYMMETRIC BIS(IMINO) COMPOUNDS Basell Polyolefine GmbH (DE) 2008-09-24 EP disclosed
WO-2007080081-A2 PROCESS FOR THE PREPARATION OF UNSYMMETRIC BIS(IMINO) COMPOUNDS BASELL POLYOLEFINE GMBH (DE) 2007-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005571-A1 Process for Preparing Imino Compounds MACO1, C9, PMS2 LMNA 80/4885CTSA 4064/4885GABRA1 3663/4885
US-20090054609-A1 Process for the Preparation of Unsymmetric Bis(Imino) Compounds FHIT, OAT, NONO LMNA 2085/4885CTSA 4726/4885GABRA1 2764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.